Robert Paccasassi - 17 Feb 2023 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
VP, QA and Reg Compliance
Signature
/s/ Robert Paccasassi
Issuer symbol
BRTX
Transactions as of
17 Feb 2023
Net transactions value
$0
Form type
4
Filing time
17 Feb 2023, 20:39:55 UTC
Previous filing
04 Nov 2022
Next filing
15 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRTX Stock Option Award $0 +88,968 $0.000000 88,968 17 Feb 2023 Common Stock 88,968 $2.91 Direct F2
holding BRTX Stock Option 8,277 17 Feb 2023 Common Stock 8,277 $5.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested.
F2 The option vests and becomes exercisable to the extent of 44,484 shares on February 17, 2023 with the remaining 44,484 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested.